SilcsBio’s drug design algorithms get patent

The technology was invented at the University of Maryland, Baltimore.

Inside Spark Baltimore. (Courtesy photo)

Algorithms used in a Spark Baltimore–based company’s software was recently patented for algorithms that will help it expand its presence in the market, according to its CEO.
SilcsBio is bringing software to the pharmaceutical process of finding new medications. The company makes software that’s designed to help pharmaceutical companies with parts of the process of developing new treatments, including a method to seek out compounds that could potentially be developed. The company licensed technology from the University of Maryland, Baltimore.

According to CEO Ken Malone, the startup’s patent covers algorithms invented by Alex MacKerell of UMB and Olgun Guvench of the University of New England, College of Pharmacy.
Using the results of the algorithms, the company’s software can present color-coded maps of a protein’s surface, which shows potential new development possibilities.
The IP also gives the startup a way to stand out.
“As we are a relatively new entrant into a well established market, the patent allows us to grow our presence by differentiating through superior performance,” Malone said.

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


‘Racist rhetoric leads to attacks’: Asian Americans and lawsuit plaintiffs take on the TikTok ban

Inside Maryland’s latest effort to support emerging businesses

This Week in Jobs: The kernel of a new career is in these 20 tech opportunities

Technically Media